ZURICH HEART HOUSE

Das Zurich Heart House schafft und vermittelt neues Wissen im Bereich Herz- und Kreislauferkrankungen. Durch seine Affiliation mit der Universität Zürich, das Redaktionsmandat des «European Heart Journal» und als Sitz der «Foundation for Cardiovascular Research» gehört das Zurich Heart House zu den wichtigsten kardiologischen Forschungs- und Ausbildungszentren in Europa.

Das Zurich Heart House ist ein Ort des kreativen Wissensaustausches zwischen Forschern, Wissenschaftlern, Klinikern, niedergelassenen Ärzten, Dozenten und Mitarbeitern. Als Denkfabrik soll es den Standort Zürich stärken und als Dienstleistungszentrum Ärzten und Patienten mit Herzkreislauferkrankungen zur Verfügung stehen.

Wenn Sie über alle unsere Veranstaltungen auf dem Laufenden bleiben wollen, abonnieren Sie unseren Newsletter HIER!

Tätigkeitsbericht 2023

 

 

Applications for the PCHF London 2025 - 2026 | 4th Edition are now OPEN!

PCHFL4thEdition

 

ZHH News

Vydia

Rising stars in cardiology: Srividya Velagapudi

Congratulations to Srividya Velagapudi, PhD, senior researcher at the Center for Molecular Cardiology of the University of Zurich, for winning the Young Investigator Award in Basic Science in 2023, for her outstanding work on Sirtuin-1, and low-density lipoprotein metabolism.

Read more here (European Heart Journal (2024) 00, 1–3)!

mehr
CMM

Postgraduate Course in Cardiometabolic Medicine 2024 | Replay videos are NOW available on demand!

The video recordings of the  2024 Postgraduate Course in Cardiometabolic Medicine are now available on demand HERE!

mehr
Florian

Research Prize of the Swiss Society of Cardiology: Congratulations to Dr. Florian Wenzl!

The 2024 Research Prize of the Swiss Society of Cardiology goes to Dr. Florian Wenzl for his outstanding original research on ‘Personalised Treatment of Acute Coronary Syndromes’ and in recognition of his exemplary dedication and evolving contributions to cardiology.

mehr
Show all ZHH news

Kardiologie News

AI-Cardiology

The cardiologist in the age of artificial intelligence: what is left for us?

No doubt, AI will transform cardiology as it is a specialty integrating vast amounts of data on patient history, symptoms, ECGs, laboratory values, and imaging of all sorts. So, what is left for the physician?

Read full article (Cardiovascular Research (2024) 00, 1–3)

mehr
Sex-Shock

Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score

Cardiogenic shock (CS) remains the primary cause of in-hospital death after acute coronary syndromes (ACS), with its plateauing mortality rates approaching 50%. However, its sex-specific performance remains unknown, and refined risk prediction strategies are warranted.

Read full article (European Heart Journal (2024) 00, 1–15)

mehr
PENK

Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score

Circulating proenkephalin (PENK) is a stable endogenous polypeptide with fast response to glomerular dysfunction and tubular damage. This study examined the predictive value of PENK for renal outcomes and mortality in patients with acute coronary syndrome (ACS).

Read full article (European Heart Journal (2024) 00, 1–17)

mehr
Show all cardiology news